患有I-III期结肠癌的患者之间的社会经济差异:检测,治疗和相对存活率
Felice N van Erning1,2, Laskarina J K Galanos1,2,3, Robin Lurvink2
1Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
International journal of cancer
|October 2, 2025
概括
社会经济地位 (SEP) 影响结肠癌的诊断和治疗. 较高的SEP与通过查和更好的治疗更早检测有关,导致轻微的生存优势.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 结肠癌是一个重大的公共卫生挑战.
- 社会经济地位 (SEP) 与各种结肠癌风险因素密切相关.
- 基于SEP的医疗保健获取和结果的差异令人担忧.
研究的目的:
- 研究社会经济地位 (SEP) 和结肠癌检测方法之间的关联.
- 检查SEP与结肠癌患者治疗特征之间的关系.
- 分析SEP对结肠癌存活率的影响.
主要方法:
- 利用了来自荷兰癌症登记处的数据,用于2015-2023年期间诊断出的I-III期结肠癌患者.
- 根据邮政编码级别的家庭收入评估SEP.
- 采用多变量逻辑回归和通用线性模型来分析关联.
主要成果:
- 与较低SEP患者相比,中等或较高SEP患者通过查更频繁地被诊断为SEP (31-33%vs23%).
- 较高的SEP与III期辅助化疗的增加率 (64-68%vs. 53%) 和较少的不良医院疗程 (44-47%vs. 54%) 相关.
- 原始的5年相对存活率为86.0% (较低的SEP),87.5% (中间的SEP) 和88.7% (较高的SEP).
结论:
- 中级和较高的社会经济地位与通过查更早诊断结肠癌有关.
- 在SEP较高的患者中,有利的治疗特征更常见.
- 更高的SEP给结肠癌患者带来了适度的生存优势,即使在调整其他因素后也是如此.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
490
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
6.0K
相关概念视频
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Comparing the Survival Analysis of Two or More Groups
561
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
